Rhythm Pharmaceuticals, Inc. RYTM 深 沪
等待开盘 10-19 09:30:00 美东时间
86.17
-1.800
-2.05%
华盛通- 最 高88.62
- 今 开88.20
- 成交量 36.70万股
- 最 低 85.91
- 昨 收 87.97
- 总市值 59.33亿
- 52周最高 122.20
- 市盈率 静 --
- 换手率 0.53%
- 52周最低 74.50
- 委 比 -12.72%
- 总股本 6885.21万
- 历史最高 122.20
- 量 比 0.48
- 振 幅 3.08%
- 历史最低 3.04
- 每 手 1
- 风险率 9.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多William Blair Initiates Coverage On Rhythm Pharmaceuticals with Outperform Rating
William Blair analyst Alethia Young initiates coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Outperform rating.
10-16 22:36
JP Morgan Maintains Overweight on Rhythm Pharmaceuticals, Lowers Price Target to $145
JP Morgan analyst Priyanka Grover maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and lowers the price target from $146 to $145.
10-16 00:01
美股大行评级 | 潜在涨幅179.23%！奥本海默上调Aurora Innovation目标价至16美元，维持"跑赢大市"评级
今日重点评级关注：奥本海默：维持Aurora Innovation"跑赢大市"评级，目标价从15美元升至16美元；富国银行：维持Applied Digital"超配"评级，目标价从50美元升至55美元
10-09 16:25
Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years
Rhythm Pharmaceuticals (NASDAQ:RYTM) has outperformed the market over the past 5 years by 38.46% on an annualized basis producing an average annual return of 50.82%. Currently, Rhythm Pharmaceuticals has a market capitalization of $6.09 billion. Buying $100 In RYTM: If an investor had bought $100 of...
10-08 22:45
Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Rhythm Pharmaceuticals, Inc. (NASDAQ: ...
09-28 21:10
美股大行评级 | 潜在涨幅768.26%！Ascendiant Capital维持RenovoRx(RNXT)"买入"评级，目标价上调至14.5美元
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从14美元升至14.5美元；HC Wainwright & Co.：维持Generate Biomedicines"买入"评级，目标价从25美元升至30美元
08-31 18:14
Deutsche Bank Initiates Coverage On Rhythm Pharmaceuticals with Hold Rating, Announces Price Target of $120
Deutsche Bank analyst David Hoang initiates coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Hold rating and announces Price Target of $120.
08-28 20:58
Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday?
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) shares are trading higher on Wednesday. On Tuesday, the company said the UK is expanding its marketing authorization for Imcivree (setmelanotide). Read Also: Why Is Rhythm Pharma Stock Jumping Today? RYTM Stock Rises On Expanded IMCIVREE Marketing Authorizat...
08-13 01:18
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
Citizens Maintains Market Outperform on Rhythm Pharmaceuticals, Raises Price Target to $160
Citizens analyst Jonathan Wolleben maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Market Outperform and raises the price target from $155 to $160.
08-05 23:11
